Abstract

E2F1/IGF-1R Loop Contributes to BRAF Inhibitor Resistance in Melanoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Deciphering root causes of intrinsic BRAF inhibitor resistance in melanoma: ushering in a new genomics case reports feature for Annals of Oncology
C Swanton ... F André
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 25
C Swanton, et. al.C Swanton ... F André
25 Feb 2014
A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib
Mary Clark ... Leslie Robinson-Bostom
JAAD Case Reports | VOL. 24
Mary Clark, et. al.Mary Clark ... Leslie Robinson-Bostom
01 Apr 2022
E2F1/IGF-R Loop Contributes to BRAF Inhibitor Resistance in Melanoma
Xiao Liu ... Jingxiu Chai
SSRN | VOL. -
Xiao Liu, et. al.Xiao Liu ... Jingxiu Chai
08 Jul 2019
Tumor heterogeneity and strategies to overcome kinase inhibitor resistance in cancer: lessons from melanoma
Vito W Rebecca ... Keiran Sm Smalley
Expert Opinion on Investigational Drugs | VOL. 20
Vito W Rebecca, et. al.Vito W Rebecca ... Keiran Sm Smalley
16 Jan 2011
View more papers

More From: The Journal of investigative dermatology

Paper Title
Journal
Date
Author
Editorial Board
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Table of Contents
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Subscription Information
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
Clinical Snippets
-
The Journal of investigative dermatology | VOL. 144
--
01 Jul 2024
View more papers